Stock EUCR EUCRATES BIOMEDICAL ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Eucrates Biomedical Acquisition Corp.

Equities

EUCR

VGG3141W1068

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index
CI
EUCRATES BIOMEDICAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt
CI
Eucrates Biomedical Acquisition to Dissolve, Liquidate
MT
Eucrates Biomedical Acquisition : Announces Liquidation - Form 8-K
PU
EUCRATES BIOMEDICAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Eucrates Biomedical Acquisition Corp. Announces Liquidation
PR
Eucrates Biomedical Acquisition : New Financial Obligation - Form 8-K
PU
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
EUCRATES BIOMEDICAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc
CI
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
AQ
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc
CI
EUCRATES BIOMEDICAL ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure (form 8-K)
AQ
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EUCR Stock
  4. News Eucrates Biomedical Acquisition Corp.